If expectations fall short, shortages or pricing issues can ensue
Jacobsson, M
However, the effects of GLP-1 analogs extend beyond T2DM, offering a range of physiological benefits, including neuroprotection, improved cognitive function, cardiac benefits, reduced blood pressure, suppressed acid secretion, enhanced lipolysis, and modulation of inflammation [10]
Investigating Combination Therapies for Enhanced Outcomes Given that obesity is a complex, multifactorial condition, combining GLP-1 agonists with other pharmacological agents may further improve treatment outcomes
Staton, Dan, High tides: Lilys $20 billion spend, Amgen preps manufacturing network to enter GLP-1 space, BioProcess International, 31 Oct, 2024, 5
Clinical Judgment Two decades of use, tens of millions of patients worldwide, and a safety record that (when you look at the full body of evidence rather than the social media horror stories) is actually quite solid for a drug this widely prescribed